 |
Vaccine consisting of 5 survivin peptides with different human leukocyte antigen restrictions |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | Dr Ulrich Granzer |
| |
Vaccine consisting of 5 survivin peptides with different human leukocyte antigen restrictions |
|---|---|
| Trade Name | |
| Orphan Indication | Ovarian cancer |
| EU Market Approval | EU |
| EU Designation Date | 2016-11-18 00:00:00 |
| Sponsor | Dr Ulrich Granzer |